Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Emmanuel M Gabriel"'
Autor:
Mizba Baksh, Biraaj Mahajan, Maria M Dufresne, Mira M Shoukry, Samuel Nussbaum, Ali Abbaszadeh-Kasbi, Mohammed Ashary, Jonathan Vandenberg, Emmanuel M Gabriel
Publikováno v:
Cancer Treatment and Research Communications, Vol 32, Iss , Pp 100609- (2022)
Background: The new diagnostic concept of liquid biopsy is based on the analysis of circulating tumor cells (CTCs) and cell-free DNA (ctDNA). In addition to providing a more comprehensive view of the tumor characteristics including molecular variatio
Externí odkaz:
https://doaj.org/article/071344ae9dc746cdb15b79f564ac2d23
Autor:
Emmanuel M. Gabriel, Brian Necela, Deborah Bahr, Sneha Vivekanandhan, Barath Shreeder, Sanjay Bagaria, Keith L. Knutson
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract In this study, we tested a novel approach of “repurposing” a biomarker typically associated with breast cancer for use in melanoma. HER2/neu is a well characterized biomarker in breast cancer for which effective anti-HER2/neu therapies a
Externí odkaz:
https://doaj.org/article/15cf9697167549baa914c2e9e20348c7
Publikováno v:
Journal of Clinical and Translational Science, Vol 4, Pp 6-6 (2020)
OBJECTIVES/GOALS: Our overall objective is to develop a directly observable and reproducible method of enhanced blood flow through tumor vessels (i.e. dynamic control) at the time of systemic treatment delivery. Our central hypothesis is that the dyn
Externí odkaz:
https://doaj.org/article/ba51f9b522454875bffd154a26129dca
Autor:
Reed Popp, Shivam Bansal, Seema Sharan, Syeda Hoorulain Ahmed, Kulkaew Belle Sukniam, Swathi Raikot, Kyle Popp, Paola Berríos Jiménez, Harsheen Kaur Manaise, Gabrielle Kowkabany, Kristopher Attwood, Emmanuel M. Gabriel
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThis study investigated demographic and socioeconomic factors contributing to disparities in the time to treatment for rectal cancer. Subgroup analysis based on age < 50 and ≥ 50 was performed to identify differences in time to treatment
Externí odkaz:
https://doaj.org/article/5edd56278fb942cc83249ee54116a4a8
Autor:
Emmanuel M. Gabriel, Kulkaew Sukniam, Kyle Popp, Gabrielle Kowkabany, Harsheen K. Manaise, Kristopher Attwood, Anthony George, Qihui Zhai, Sanjay P. Bagaria, Keith L. Knutson, Joseph J. Skitzki, Matthew W. Robertson, Tri A. Dinh
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 4, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/8e2713ceecb14b7e8113cd3d0cc81638
Autor:
Emmanuel M. Gabriel, Minhyung Kim, Daniel T. Fisher, Catherine Mangum, Kristopher Attwood, Wenyan Ji, Debabrata Mukhopadhyay, Sanjay P. Bagaria, Matthew W. Robertson, Tri A. Dinh, Keith L. Knutson, Joseph J. Skitzki, Michael B. Wallace
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Aberrancies in the tumor microvasculature limit the systemic delivery of anticancer agents, which impedes tumor response. Using human intravital microscopy (HIVM), we hypothesized that HIVM would be feasible in patients with peritoneal carci
Externí odkaz:
https://doaj.org/article/8b34f51c24a64fa09479af5932207948
Publikováno v:
Frontiers in Oncology. 13
Sarcomas comprise a vast and heterogenous group of rare tumors. Because of their diversity, it is challenging to study sarcomas as a whole with regard to their biological and molecular characteristics. This diverse set of tumors may also possess diff
Autor:
Turab Mohammed, Rohit Gosain, Navpreet Rana, Riccardo Lemini, Katy Wang, Asna Agha, Arun Neupane, Emmanuel M Gabriel, Steven Nurkin, Patrick Boland
Publikováno v:
Hematology/Oncology and Stem Cell Therapy. 16
Autor:
Sacha P. Broccard, Ali Abbaszadeh Kasbi, Sanjay P. Bagaria, Jeremy Jones, Mira Shoudry, Emmanuel M. Gabriel
Publikováno v:
J Gastrointest Oncol
OBJECTIVE: In this review, we summarize ongoing clinical trials involving liquid biopsies (LB) for colorectal cancer (CRC), outlining the current landscape and the future implementation of this technology. We also describe the current use of LB in CR
Autor:
Emmanuel M. Gabriel, Brian Necela, Deborah Bahr, Jamie Kaplan, Kristopher Attwood, Keith Knutson
Publikováno v:
Cancer Research. 82:5371-5371
INTRODUCTION: HER2/neu is a potent biomarker for which anti-HER2/neu antibodies offer significant responses. However, many cancers, such as melanoma, have less than 5% expression of HER2/neu. The purpose of this study was to determine whether induced